How to set up a pharmacovigilance system?

Webinar: Setting up a pharmacovigilance system in Europe. Where to start? What to consider?

Setting up a pharmacovigilance system is not as straightforward an answer as it may sound. There are many aspects to consider, which can seem complicated, especially when you must focus on developing your product. In the first part of this webinar, our experts lay out all the steps necessary to set up a system and discuss best practices in critical areas.

In the webinar’s second part, we dive deeply into actual best practices to overcome day-to-day challenges. Our experts welcome questions from real-world challenges to help you meet pharmacovigilance requirements efficiently. Whether expanding to the EU or bringing your first product to market here, join us if you’re planning to establish a pharmacovigilance system in Europe and set yourself up for success.

Thinking how to ensure drug safety?

Let’s talk how we can team up to optimize your pharmacovigilance activities in Europe.

Who Should Attend?

Professionals from drug safety:

  • Global QPPVs / Deputies
  • QPPV Office managers
  • Heads of Pharmacovigilance
  • Heads of Pharmacovigilance Technologies
  • Drug Safety Managers and Leaders

Duration: 1 hour.

Speakers:

  • Martijn van de Leur, Head of Global Pharmacovigilance
  • Olga Asimaki, International QPPV / Head of Medical Information
  • Albert Bekfi, Head of Pharmacovigilance Operations
Martijn van de Leur

Martijn van de Leur

Head of Global Pharmacovigilance

Sign up for the webinar. Stay up to date.

Other content that might interest you:

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Building Health Literacy: The Value of Good Writing

Building Health Literacy: The Value of Good Writing

Scientists, doctors, and health authorities often use written communication to present their research, opinions, or guidelines to the patients. While the questions they approach may be complex, the language should not. In medical documents, misinterpreted information may endanger the health and life of a patient. Thus, the main goal in medical writing is to convey the message clearly and concisely to avoid misinterpretation.

read more
Proper Publicizing in CEECs – Path to Successful Social Media Commercials

Proper Publicizing in CEECs – Path to Successful Social Media Commercials

With the growth of social media network users all over the world, there is no doubt that one of the most widely used channels for promoting is social media. Statistics show that Facebook and Instagram were used actively with more than 3.4 billion people daily by January 2020. Therefore, since medical devices and over-the-counter medicines are being more often promoted by commercials on social media nowadays, there is a greater risk of hidden or misleading advertisements.

read more
What do you need to know while preparing RMP for EAEU and CIS region?

What do you need to know while preparing RMP for EAEU and CIS region?

Preparation of Risk Management Plan (RMP) for a specific medicinal product usually is the responsibility of the Qualified Person Responsible for Pharmacovigilance (QPPV) and its team. Thus, QPPVs and their team’s should be familiar with legislation requirements for RMP preparation in different regions. Within this article, we will concentrate on the Eurasian Economic Union (EAEU) and identify specific conditions of EAEU countries as well as to try to understand the expectations of Competent Authorities in this region.

read more

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information